Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $221,646 - $238,533
-1,436 Reduced 41.04%
2,063 $341,000
Q1 2023

May 04, 2023

SELL
$151.05 - $180.26 $108,000 - $128,885
-715 Reduced 16.97%
3,499 $542,000
Q4 2022

Feb 06, 2023

BUY
$160.2 - $179.79 $190,638 - $213,950
1,190 Added 39.35%
4,214 $744,000
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $94,216 - $104,839
-584 Reduced 16.19%
3,024 $494,000
Q2 2022

Aug 08, 2022

SELL
$168.19 - $186.01 $10,091 - $11,160
-60 Reduced 1.64%
3,608 $640,000
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $19,609 - $22,269
-124 Reduced 3.27%
3,668 $650,000
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $415,085 - $460,552
-2,662 Reduced 41.25%
3,792 $636,000
Q2 2021

Aug 12, 2021

SELL
$159.48 - $171.07 $115,782 - $124,196
-726 Reduced 10.11%
6,454 $1.06 Million
Q1 2021

May 12, 2021

BUY
$153.07 - $170.48 $85,872 - $95,639
561 Added 8.48%
7,180 $1.17 Million
Q4 2020

Feb 11, 2021

SELL
$137.11 - $157.38 $22,211 - $25,495
-162 Reduced 2.39%
6,619 $1.13 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $1,403 - $1,538
-10 Reduced 0.15%
6,781 $948,000
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $24,473 - $29,546
-190 Reduced 2.72%
6,791 $955,000
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $129,700 - $179,706
1,167 Added 20.07%
6,981 $1.04 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $51,510 - $59,161
404 Added 7.47%
5,814 $879,000
Q3 2019

Nov 20, 2019

BUY
$126.95 - $142.14 $114,508 - $128,210
902 Added 20.01%
5,410 $710,000
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $37,115 - $40,819
283 Added 6.7%
4,508 $595,000
Q1 2019

May 16, 2019

BUY
$125.72 - $139.79 $187,197 - $208,147
1,489 Added 54.42%
4,225 $591,000
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $336,090 - $404,490
2,736 New
2,736 $353,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Full Sail Capital, LLC Portfolio

Follow Full Sail Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Full Sail Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Full Sail Capital, LLC with notifications on news.